SPY760.34+0.07%QQQ690.59+0.03%BTC/USD71,736.10−2.96%DIA525.22+0.15%GLD356.07−2.49%TLT79.86−1.32%

Biohaven Ltd

BHVNNYSE

Trade with Public

$14.34

-0.85-5.6%

Last update: Nov 12, 1:43 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Biohaven (BHVN) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Biohaven (BHVN) stock.

Analyst Consensus — 19 Analysts

1S.Buy

17Buy

1Hold

# Analysts19

Latest Upgrades and Downgrades for Biohaven Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$19→$21
—	Canaccord Genuity	Sumant Kulkarni	PT Raise	Buy	$21→$32
—	RBC Capital	Leonid Timashev	PT Raise	Sector Perform	$19→$22
—	HC Wainwright & Co.	Douglas Tsao	Maintained	Neutral	$10
—	RBC Capital	Leonid Timashev	Downgrade	Outperform→Sector Perform	$23→$19
—	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$18→$19
—	RBC Capital	Leonid Timashev	PT Raise	Outperform	$22→$23
—	B of A Securities	Jason Gerberry	Downgrade	Neutral→Underperform	$12→$11
—	HC Wainwright & Co.	Douglas Tsao	Maintained	Neutral	$10
—	Morgan Stanley	Terence Flynn	PT Cut	Overweight	$21→$18
—	RBC Capital	Leonid Timashev	PT Cut	Outperform	$23→$22
—	Citigroup	Samantha Semenkow	PT Raise	Buy	$14→$17
—	TD Cowen	Tyler Van Buren	PT Raise	Buy	$15→$30
—	HC Wainwright & Co.	Douglas Tsao	PT Cut	Neutral	$11→$10
—	RBC Capital	Leonid Timashev	PT Raise	Outperform	$22→$23
—	RBC Capital	Leonid Timashev	Upgrade	Sector Perform→Outperform	$9→$22
—	Morgan Stanley	Terence Flynn	PT Cut	Overweight	$26→$21
—	HC Wainwright & Co.	Douglas Tsao	Maintained	Neutral	$11
—	HC Wainwright & Co.	Douglas Tsao	Downgrade	Buy→Neutral	$30→$11
—	UBS	Ashwani Verma	Downgrade	Buy→Neutral	$26→$11

Biohaven Ltd

Biohaven (BHVN) Stock Price Target 2026

Latest Upgrades and Downgrades for Biohaven Stock

Biohaven (BHVN) Stock Price Target 2026

Latest Upgrades and Downgrades for Biohaven Stock

Analyst Ratings News

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $21

PRO
Canaccord Genuity Maintains Buy on Biohaven, Raises Price Target to $32

PRO
RBC Capital Maintains Sector Perform on Biohaven, Raises Price Target to $22

PRO
HC Wainwright & Co. Reiterates Neutral on Biohaven, Maintains $10 Price Target

PRO
RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $21

PRO
Canaccord Genuity Maintains Buy on Biohaven, Raises Price Target to $32

PRO
RBC Capital Maintains Sector Perform on Biohaven, Raises Price Target to $22

PRO
HC Wainwright & Co. Reiterates Neutral on Biohaven, Maintains $10 Price Target

PRO
RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

Biohaven Ltd

Biohaven (BHVN) Stock Price Target 2026

Latest Upgrades and Downgrades for Biohaven Stock

Biohaven (BHVN) Stock Price Target 2026

Latest Upgrades and Downgrades for Biohaven Stock

Analyst Ratings News

PROMorgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $21

PROCanaccord Genuity Maintains Buy on Biohaven, Raises Price Target to $32

PRORBC Capital Maintains Sector Perform on Biohaven, Raises Price Target to $22

PROHC Wainwright & Co. Reiterates Neutral on Biohaven, Maintains $10 Price Target

PRORBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

PROMorgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

People Also Watch

People Also Watch

Analyst Ratings News

PROMorgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $21

PROCanaccord Genuity Maintains Buy on Biohaven, Raises Price Target to $32

PRORBC Capital Maintains Sector Perform on Biohaven, Raises Price Target to $22

PROHC Wainwright & Co. Reiterates Neutral on Biohaven, Maintains $10 Price Target

PRORBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

PROMorgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $21

PRO
Canaccord Genuity Maintains Buy on Biohaven, Raises Price Target to $32

PRO
RBC Capital Maintains Sector Perform on Biohaven, Raises Price Target to $22

PRO
HC Wainwright & Co. Reiterates Neutral on Biohaven, Maintains $10 Price Target

PRO
RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $21

PRO
Canaccord Genuity Maintains Buy on Biohaven, Raises Price Target to $32

PRO
RBC Capital Maintains Sector Perform on Biohaven, Raises Price Target to $22

PRO
HC Wainwright & Co. Reiterates Neutral on Biohaven, Maintains $10 Price Target

PRO
RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

PRO
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19